Follow us

Amryt Pharma (AMYT)

Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

25 September 2018

Presentation by Amryt Pharma CCO, David Allmond.

Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses.

The team – 00:27
The vision – 02:12
Amryt overview – 04:04
Commercial & development pipeline – 06:00
Strategy – 3 pillars of growth – 07:43
Lojuxta – 10:02
Epidermolysis Bullosa (EB) AP101 – 12:20
AP103 – building an EB franchise – Gene Therapy Platform – 18:26
In-License Opportunities – 21:07
Financials – 22:16
Investment case – 22:55
Q&A – 24:18


The presentation slides can be viewed here.

Listen on the go


PIWORLD provides investors with the latest news and insight about listed companies and their management through either live or recorded investor presentations, management interviews, Capital Market Days and corporate overviews, together with interviews with leading fund managers or esteemed private investors in the small cap world.

Our Services

PIWORLD delivers high quality audio and video content to present anything from full-year & interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.